Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Boston Scientific chief executive ‘to turn attention to core challenges’

Boston Scientific chief executive ‘to turn attention to core challenges’

9th June 2008

Boston Scientific has announced that president and chief executive officer Jim Tobin is to extend his tenure in this position at the company and to turn his attention and energies to address the core challenges affecting the company.

These include those relating to the development of human capital, the simplification and streamlining of operations, organisational efficiency and strategy.

Over the past two years, Mr Tobin has focused much of his time on the integration of Guidant into the firm.

Pete Nicholas, co-founder and chairman of the board of Boston Scientific, said: “After two years of Jim’s intense focus and successful leadership, our CRM business and its new management team are re-vitalized and well positioned to achieve the enormous potential of this business.”

He added that the firm is committed to the delivery of innovation, increased shareholder value, profitable growth and a stronger future for Boston Scientific, with the board believing that Mr Tobin is the best person to continue these achievements.

Boston Scientific also announced the retirement of Paul LaViolette as chief operating officer of the firm and appointment of Fred Colen as president of its cardiac rhythm management group.

In April 2008, Boston Scientific announced the appointment of Drake University Law School graduate Timothy Pratt as general counsel of the company.

We currently have 6 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.